Cleared Traditional

K896528 - SFA MODULE

K896528 is the FDA 510(k) clearance for SFA MODULE by Life Sciences Manufacturing, Inc.. It is a Class 2 Cardiovascular device (product code DXG) cleared through the Traditional 510(k) pathway after a 71-day FDA review.

K896528 · Life Sciences Manufacturing, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1990
Decision
71d
Days
Class 2
Risk

K896528 is an FDA 510(k) clearance for the SFA MODULE. Classified as Computer, Diagnostic, Pre-programmed, Single-function (product code DXG), Class II - Special Controls.

Submitted by Life Sciences Manufacturing, Inc. (West Lebanon, US). The FDA issued a Cleared decision on January 26, 1990 after a review of 71 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1435 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Life Sciences Manufacturing, Inc. devices

Submission Details

510(k) Number K896528 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 16, 1989
Decision Date January 26, 1990
Days to Decision 71 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
54d faster than avg
Panel avg: 125d · This submission: 71d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DXG Computer, Diagnostic, Pre-programmed, Single-function
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1435
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXG Computer, Diagnostic, Pre-programmed, Single-function

All 80
Devices cleared under the same product code (DXG) and FDA review panel - the closest regulatory comparables to K896528.
CONTINUOUS CARDIAC OUTPUT SYSTEM
K932414 · Abbott Laboratories · Nov 1994
CARDIAC OUTPUT COMPUTER, MODEL COM-3
K896930 · Baxter Healthcare Corp · Jul 1990
NOVA MICROSONICS DATAVUE ECHO ANALYSIS SYSTEM
K897004 · Advanced Technology Laboratories, Inc. · Mar 1990
CPM-1 SYSTEM OXIMETER/CARDIAC OUTPUT COMPUTER
K893392 · Baxter Healthcare Corp · Jun 1989
TYPE 9320 CARDIAC OUTPUT SYSTEM ATHENA
K884122 · S & W Medico Teknik · Apr 1989
3000 PHYSIOLOGICAL MONITOR
K880301 · Datascope Corp. · Aug 1988